Current state in biotechnology in canine and feline reproduction

Biotechnology has proceeded much further in cats than in canines, although the pregnancy rate after in vitro maturation (IVM), IVC and embryo transfer (ET) is still relatively low. The use of AI with frozen–thawed semen as a breeding tool to overcome breeding incompatibility or to preserve male genetic material has been limited in felines in contrast to the situation in domestic dogs and foxes. In many research scenarios and endangered felid species programs, the in vitro production of feline embryos with subsequent transfer has complemented the use of AI. Improvement of IVM, in vitro fertilization (IVF) and embryo culture coupled with ovarian tissue grafting, cryobanking of follicles, oocytes, semen, or embryos, with subsequent ET into surrogate females, may render this technology feasible for use in endangered wild felids. In canines, reliable systems for in vitro production of embryos, embryo cryopreservation and transfer are yet to be developed. The refinement of invasive fertilization techniques, such as intracytoplasmic sperm injection (ICSI), may eventually provide a tool for removal of recipient oocyte nuclei and transfer of selected embryonic or somatic cell donor nuclei into domestic cat ooplasm, thereby providing a tool for genetic modification, or for preservation of valuable genetic material.